APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dutasteride

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dutasteride Market Outlook and Growth Opportunities 2026

20 December 2025195 pages

Choose your research edition.

Industry ResearchDutasteride Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Dutasteride Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Dutasteride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dutasteride Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dutasteride Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Dutasteride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dutasteride market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dutasteride market include GSK, Amneal Pharma, Apotex, Bionpharma, Breckenridge Pharmaceutical, Marksans Pharma, Rising Pharmaceuticals, Zydus and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dutasteride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dutasteride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dutasteride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dutasteride market size, projected growth trends, production technologies, key applications, and end-use industries.

Dutasteride Segment by Company

GSK

Amneal Pharma

Apotex

Bionpharma

Breckenridge Pharmaceutical

Marksans Pharma

Rising Pharmaceuticals

Zydus

Mylan

Teva

Dutasteride Segment by Type

Type I

Type II

Dutasteride Segment by Application

Hospital

Drug Store

Dutasteride Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Dutasteride status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dutasteride market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dutasteride significant trends, drivers, influence factors in global and regions.

6. To analyze Dutasteride competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dutasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dutasteride market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dutasteride industry.

Chapter 3: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dutasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dutasteride in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dutasteride Industry Trends Table 2. Dutasteride Industry Drivers Table 3. Dutasteride Industry Opportunities and Challenges Table 4. Dutasteride Industry Restraints Table 5. Global Dutasteride Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dutasteride Revenue Share by Company (2021-2026) Table 7. Global Dutasteride Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Dutasteride Sales Volume Share by Company (2021-2026) Table 9. Global Dutasteride Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dutasteride Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dutasteride Key Company Manufacturing Base & Headquarters Table 12. Global Dutasteride Company, Product Type & Application Table 13. Global Dutasteride Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dutasteride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Type I Table 18. Significant Companies of Type II Table 19. Global Dutasteride Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Dutasteride Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Dutasteride Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Dutasteride Sales Volume Share by Type (2021-2026) Table 23. Global Dutasteride Sales Volume Share by Type (2027-2032) Table 24. Global Dutasteride Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dutasteride Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Dutasteride Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Dutasteride Sales Value Share by Type (2021-2026) Table 28. Global Dutasteride Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Drug Store Table 31. Global Dutasteride Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Dutasteride Sales Volume by Application (2021-2026) & (W Units) Table 33. Global Dutasteride Sales Volume by Application (2027-2032) & (W Units) Table 34. Global Dutasteride Sales Volume Share by Application (2021-2026) Table 35. Global Dutasteride Sales Volume Share by Application (2027-2032) Table 36. Global Dutasteride Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Dutasteride Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Dutasteride Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Dutasteride Sales Value Share by Application (2021-2026) Table 40. Global Dutasteride Sales Value Share by Application (2027-2032) Table 41. Global Dutasteride Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Dutasteride Sales by Region (2021-2026) & (W Units) Table 43. Global Dutasteride Sales Market Share by Region (2021-2026) Table 44. Global Dutasteride Sales by Region (2027-2032) & (W Units) Table 45. Global Dutasteride Sales Market Share by Region (2027-2032) Table 46. Global Dutasteride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Dutasteride Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Dutasteride Sales Value Share by Region (2021-2026) Table 49. Global Dutasteride Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Dutasteride Sales Value Share by Region (2027-2032) Table 51. Global Dutasteride Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Dutasteride Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Dutasteride Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Global Dutasteride Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Dutasteride Sales by Country (2021-2026) & (W Units) Table 56. Global Dutasteride Sales Market Share by Country (2021-2026) Table 57. Global Dutasteride Sales by Country (2027-2032) & (W Units) Table 58. Global Dutasteride Sales Market Share by Country (2027-2032) Table 59. Global Dutasteride Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Dutasteride Sales Value Market Share by Country (2021-2026) Table 61. Global Dutasteride Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Dutasteride Sales Value Market Share by Country (2027-2032) Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. GSK Dutasteride Product Portfolio Table 67. GSK Recent Development Table 68. Amneal Pharma Company Information Table 69. Amneal Pharma Business Overview Table 70. Amneal Pharma Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Amneal Pharma Dutasteride Product Portfolio Table 72. Amneal Pharma Recent Development Table 73. Apotex Company Information Table 74. Apotex Business Overview Table 75. Apotex Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Apotex Dutasteride Product Portfolio Table 77. Apotex Recent Development Table 78. Bionpharma Company Information Table 79. Bionpharma Business Overview Table 80. Bionpharma Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bionpharma Dutasteride Product Portfolio Table 82. Bionpharma Recent Development Table 83. Breckenridge Pharmaceutical Company Information Table 84. Breckenridge Pharmaceutical Business Overview Table 85. Breckenridge Pharmaceutical Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Breckenridge Pharmaceutical Dutasteride Product Portfolio Table 87. Breckenridge Pharmaceutical Recent Development Table 88. Marksans Pharma Company Information Table 89. Marksans Pharma Business Overview Table 90. Marksans Pharma Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Marksans Pharma Dutasteride Product Portfolio Table 92. Marksans Pharma Recent Development Table 93. Rising Pharmaceuticals Company Information Table 94. Rising Pharmaceuticals Business Overview Table 95. Rising Pharmaceuticals Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Rising Pharmaceuticals Dutasteride Product Portfolio Table 97. Rising Pharmaceuticals Recent Development Table 98. Zydus Company Information Table 99. Zydus Business Overview Table 100. Zydus Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Zydus Dutasteride Product Portfolio Table 102. Zydus Recent Development Table 103. Mylan Company Information Table 104. Mylan Business Overview Table 105. Mylan Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Mylan Dutasteride Product Portfolio Table 107. Mylan Recent Development Table 108. Teva Company Information Table 109. Teva Business Overview Table 110. Teva Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Teva Dutasteride Product Portfolio Table 112. Teva Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Dutasteride Distributors List Table 116. Dutasteride Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Dutasteride Product Image Figure 2. Global Dutasteride Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dutasteride Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dutasteride Sales (2021-2032) & (W Units) Figure 5. Global Dutasteride Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dutasteride Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Type I Image Figure 10. Type II Image Figure 11. Global Dutasteride Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Dutasteride Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Dutasteride Sales Volume Share by Type (2021-2032) Figure 14. Global Dutasteride Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Dutasteride Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Dutasteride Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drug Store Image Figure 19. Global Dutasteride Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Dutasteride Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Dutasteride Sales Volume Share by Application (2021-2032) Figure 22. Global Dutasteride Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Dutasteride Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Dutasteride Sales Value Share by Application (2021-2032) Figure 25. Global Dutasteride Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 26. Global Dutasteride Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Dutasteride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Dutasteride Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Dutasteride Sales Value (2021-2032) & (US$ Million) Figure 30. North America Dutasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Dutasteride Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Dutasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Dutasteride Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Dutasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Dutasteride Sales Value (2021-2032) & (US$ Million) Figure 36. South America Dutasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Dutasteride Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Dutasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Dutasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Dutasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Dutasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Dutasteride Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Dutasteride Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Type I
  • Type II
Applications
  • Hospital
  • Drug Store
Companies covered
  • GSK
  • Amneal Pharma
  • Apotex
  • Bionpharma
  • Breckenridge Pharmaceutical
  • Marksans Pharma
  • Rising Pharmaceuticals
  • Zydus
  • Mylan
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dutasteride Sales Value (2021-2032)
  4. 1.2.2 Global Dutasteride Sales Volume (2021-2032)
  5. 1.2.3 Global Dutasteride Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dutasteride Market Dynamics
  1. 2.1 Dutasteride Industry Trends
  2. 2.2 Dutasteride Industry Drivers
  3. 2.3 Dutasteride Industry Opportunities and Challenges
  4. 2.4 Dutasteride Industry Restraints
3 Dutasteride Market by Company
  1. 3.1 Global Dutasteride Company Revenue Ranking in 2025
  2. 3.2 Global Dutasteride Revenue by Company (2021-2026)
  3. 3.3 Global Dutasteride Sales Volume by Company (2021-2026)
  4. 3.4 Global Dutasteride Average Price by Company (2021-2026)
  5. 3.5 Global Dutasteride Company Ranking (2024-2026)
  6. 3.6 Global Dutasteride Company Manufacturing Base and Headquarters
  7. 3.7 Global Dutasteride Company Product Type and Application
  8. 3.8 Global Dutasteride Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dutasteride Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dutasteride Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dutasteride Market by Type
  1. 4.1 Dutasteride Type Introduction
  2. 4.1.1 Type I
  3. 4.1.2 Type II
  4. 4.2 Global Dutasteride Sales Volume by Type
  5. 4.2.1 Global Dutasteride Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dutasteride Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Dutasteride Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Dutasteride Sales Value by Type
  9. 4.3.1 Global Dutasteride Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dutasteride Sales Value by Type (2021-2032)
  11. 4.3.3 Global Dutasteride Sales Value Share by Type (2021-2032)
5 Dutasteride Market by Application
  1. 5.1 Dutasteride Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Dutasteride Sales Volume by Application
  5. 5.2.1 Global Dutasteride Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Dutasteride Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Dutasteride Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Dutasteride Sales Value by Application
  9. 5.3.1 Global Dutasteride Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Dutasteride Sales Value by Application (2021-2032)
  11. 5.3.3 Global Dutasteride Sales Value Share by Application (2021-2032)
6 Dutasteride Regional Sales and Value Analysis
  1. 6.1 Global Dutasteride Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dutasteride Sales by Region (2021-2032)
  3. 6.2.1 Global Dutasteride Sales by Region: 2021-2026
  4. 6.2.2 Global Dutasteride Sales by Region (2027-2032)
  5. 6.3 Global Dutasteride Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dutasteride Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dutasteride Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dutasteride Sales Value by Region (2027-2032)
  9. 6.5 Global Dutasteride Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dutasteride Sales Value (2021-2032)
  12. 6.6.2 North America Dutasteride Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dutasteride Sales Value (2021-2032)
  15. 6.7.2 Europe Dutasteride Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dutasteride Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dutasteride Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dutasteride Sales Value (2021-2032)
  21. 6.9.2 South America Dutasteride Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dutasteride Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dutasteride Sales Value Share by Country, 2025 VS 2032
7 Dutasteride Country-level Sales and Value Analysis
  1. 7.1 Global Dutasteride Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dutasteride Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dutasteride Sales by Country (2021-2032)
  4. 7.3.1 Global Dutasteride Sales by Country (2021-2026)
  5. 7.3.2 Global Dutasteride Sales by Country (2027-2032)
  6. 7.4 Global Dutasteride Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dutasteride Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dutasteride Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dutasteride Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dutasteride Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dutasteride Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dutasteride Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dutasteride Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dutasteride Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dutasteride Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dutasteride Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dutasteride Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dutasteride Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dutasteride Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dutasteride Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dutasteride Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dutasteride Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dutasteride Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dutasteride Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dutasteride Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dutasteride Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dutasteride Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dutasteride Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dutasteride Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dutasteride Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dutasteride Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dutasteride Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dutasteride Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dutasteride Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dutasteride Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dutasteride Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dutasteride Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dutasteride Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dutasteride Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dutasteride Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dutasteride Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dutasteride Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dutasteride Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dutasteride Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dutasteride Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dutasteride Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dutasteride Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dutasteride Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dutasteride Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dutasteride Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dutasteride Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dutasteride Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dutasteride Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dutasteride Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dutasteride Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dutasteride Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dutasteride Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dutasteride Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dutasteride Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dutasteride Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dutasteride Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dutasteride Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dutasteride Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dutasteride Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dutasteride Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dutasteride Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dutasteride Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dutasteride Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dutasteride Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dutasteride Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dutasteride Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dutasteride Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dutasteride Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dutasteride Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dutasteride Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dutasteride Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dutasteride Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dutasteride Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dutasteride Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dutasteride Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dutasteride Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dutasteride Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dutasteride Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dutasteride Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dutasteride Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dutasteride Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dutasteride Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dutasteride Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dutasteride Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dutasteride Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dutasteride Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dutasteride Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Dutasteride Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Dutasteride Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Amneal Pharma
  8. 8.2.1 Amneal Pharma Company Information
  9. 8.2.2 Amneal Pharma Business Overview
  10. 8.2.3 Amneal Pharma Dutasteride Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharma Dutasteride Product Portfolio
  12. 8.2.5 Amneal Pharma Recent Developments
  13. 8.3 Apotex
  14. 8.3.1 Apotex Company Information
  15. 8.3.2 Apotex Business Overview
  16. 8.3.3 Apotex Dutasteride Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Apotex Dutasteride Product Portfolio
  18. 8.3.5 Apotex Recent Developments
  19. 8.4 Bionpharma
  20. 8.4.1 Bionpharma Company Information
  21. 8.4.2 Bionpharma Business Overview
  22. 8.4.3 Bionpharma Dutasteride Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bionpharma Dutasteride Product Portfolio
  24. 8.4.5 Bionpharma Recent Developments
  25. 8.5 Breckenridge Pharmaceutical
  26. 8.5.1 Breckenridge Pharmaceutical Company Information
  27. 8.5.2 Breckenridge Pharmaceutical Business Overview
  28. 8.5.3 Breckenridge Pharmaceutical Dutasteride Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Breckenridge Pharmaceutical Dutasteride Product Portfolio
  30. 8.5.5 Breckenridge Pharmaceutical Recent Developments
  31. 8.6 Marksans Pharma
  32. 8.6.1 Marksans Pharma Company Information
  33. 8.6.2 Marksans Pharma Business Overview
  34. 8.6.3 Marksans Pharma Dutasteride Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Marksans Pharma Dutasteride Product Portfolio
  36. 8.6.5 Marksans Pharma Recent Developments
  37. 8.7 Rising Pharmaceuticals
  38. 8.7.1 Rising Pharmaceuticals Company Information
  39. 8.7.2 Rising Pharmaceuticals Business Overview
  40. 8.7.3 Rising Pharmaceuticals Dutasteride Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Rising Pharmaceuticals Dutasteride Product Portfolio
  42. 8.7.5 Rising Pharmaceuticals Recent Developments
  43. 8.8 Zydus
  44. 8.8.1 Zydus Company Information
  45. 8.8.2 Zydus Business Overview
  46. 8.8.3 Zydus Dutasteride Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Zydus Dutasteride Product Portfolio
  48. 8.8.5 Zydus Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Dutasteride Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Dutasteride Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Teva
  56. 8.10.1 Teva Company Information
  57. 8.10.2 Teva Business Overview
  58. 8.10.3 Teva Dutasteride Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Teva Dutasteride Product Portfolio
  60. 8.10.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dutasteride Value Chain Analysis
  2. 9.1.1 Dutasteride Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dutasteride Sales Mode & Process
  6. 9.2 Dutasteride Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dutasteride Distributors
  9. 9.2.3 Dutasteride Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst